NANCY SNOW: Open Payments
NPI 1982337671 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 19 payments from 11 companies in 2025. Trend: 2023 $232 · 2024 $434 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $95 |
| Novo Nordisk Inc | 3 | $80 |
| Lilly USA, LLC | 3 | $58 |
| SANOFI-AVENTIS U.S. LLC | 1 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Globus Medical, Inc. | 1 | $17 |
Products named: OTEZLA, MOUNJARO, Ozempic, TZIELD, Dexcom G6 Transmitter, Wegovy, Veozah, AIRSUPRA.
Industry payments across MD — which companies pay providers there.
